QQQ   337.27 (+1.86%)
AAPL   175.05 (+1.37%)
MSFT   318.52 (+1.44%)
META   246.85 (+1.80%)
GOOGL   122.83 (+1.65%)
AMZN   118.15 (+2.29%)
TSLA   176.89 (+1.74%)
NVDA   316.78 (+4.97%)
NIO   7.82 (-2.62%)
BABA   85.77 (-5.41%)
AMD   107.93 (+4.03%)
T   16.55 (-0.66%)
F   11.64 (+1.22%)
MU   67.57 (+4.08%)
CGC   1.05 (+0.00%)
GE   104.01 (+0.52%)
DIS   93.76 (+1.07%)
AMC   5.07 (-0.59%)
PFE   36.48 (-0.73%)
PYPL   61.27 (-0.31%)
NFLX   371.29 (+9.22%)
QQQ   337.27 (+1.86%)
AAPL   175.05 (+1.37%)
MSFT   318.52 (+1.44%)
META   246.85 (+1.80%)
GOOGL   122.83 (+1.65%)
AMZN   118.15 (+2.29%)
TSLA   176.89 (+1.74%)
NVDA   316.78 (+4.97%)
NIO   7.82 (-2.62%)
BABA   85.77 (-5.41%)
AMD   107.93 (+4.03%)
T   16.55 (-0.66%)
F   11.64 (+1.22%)
MU   67.57 (+4.08%)
CGC   1.05 (+0.00%)
GE   104.01 (+0.52%)
DIS   93.76 (+1.07%)
AMC   5.07 (-0.59%)
PFE   36.48 (-0.73%)
PYPL   61.27 (-0.31%)
NFLX   371.29 (+9.22%)
QQQ   337.27 (+1.86%)
AAPL   175.05 (+1.37%)
MSFT   318.52 (+1.44%)
META   246.85 (+1.80%)
GOOGL   122.83 (+1.65%)
AMZN   118.15 (+2.29%)
TSLA   176.89 (+1.74%)
NVDA   316.78 (+4.97%)
NIO   7.82 (-2.62%)
BABA   85.77 (-5.41%)
AMD   107.93 (+4.03%)
T   16.55 (-0.66%)
F   11.64 (+1.22%)
MU   67.57 (+4.08%)
CGC   1.05 (+0.00%)
GE   104.01 (+0.52%)
DIS   93.76 (+1.07%)
AMC   5.07 (-0.59%)
PFE   36.48 (-0.73%)
PYPL   61.27 (-0.31%)
NFLX   371.29 (+9.22%)
QQQ   337.27 (+1.86%)
AAPL   175.05 (+1.37%)
MSFT   318.52 (+1.44%)
META   246.85 (+1.80%)
GOOGL   122.83 (+1.65%)
AMZN   118.15 (+2.29%)
TSLA   176.89 (+1.74%)
NVDA   316.78 (+4.97%)
NIO   7.82 (-2.62%)
BABA   85.77 (-5.41%)
AMD   107.93 (+4.03%)
T   16.55 (-0.66%)
F   11.64 (+1.22%)
MU   67.57 (+4.08%)
CGC   1.05 (+0.00%)
GE   104.01 (+0.52%)
DIS   93.76 (+1.07%)
AMC   5.07 (-0.59%)
PFE   36.48 (-0.73%)
PYPL   61.27 (-0.31%)
NFLX   371.29 (+9.22%)

Allstate (NYSE:ALL) PT Raised to $149.00

Allstate (NYSE:ALL - Get Rating) had its price target boosted by analysts at Bank of America from $146.00 to $149.00 in a research note issued to investors on Thursday, The Fly reports. Bank of America's price objective suggests a potential upside of 25.33% from the company's current price.

A number of other equities analysts also recently commented on ALL. Roth Capital restated a "buy" rating on shares of Allstate in a research note on Thursday, February 2nd. Barclays reduced their price objective on Allstate from $125.00 to $122.00 and set an "equal weight" rating for the company in a research report on Wednesday, April 12th. StockNews.com initiated coverage on Allstate in a report on Thursday. They set a "hold" rating on the stock. Citigroup dropped their target price on Allstate from $150.00 to $138.00 in a report on Tuesday, April 18th. Finally, Piper Sandler boosted their target price on Allstate from $144.00 to $150.00 and gave the stock an "overweight" rating in a report on Tuesday, April 4th. One research analyst has rated the stock with a sell rating, six have given a hold rating and eight have issued a buy rating to the company. According to MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $141.31.

Allstate Stock Down 0.1 %


Allstate stock traded down $0.11 during midday trading on Thursday, hitting $118.89. The stock had a trading volume of 1,512,307 shares, compared to its average volume of 1,895,468. The company has a current ratio of 0.41, a quick ratio of 0.41 and a debt-to-equity ratio of 0.55. The stock has a market cap of $31.25 billion, a P/E ratio of -13.40, a P/E/G ratio of 4.17 and a beta of 0.58. Allstate has a 12 month low of $103.20 and a 12 month high of $142.15. The business has a fifty day moving average price of $113.84 and a 200 day moving average price of $125.77.

Allstate (NYSE:ALL - Get Rating) last announced its quarterly earnings data on Thursday, May 4th. The insurance provider reported ($1.30) earnings per share for the quarter, beating the consensus estimate of ($1.94) by $0.64. Allstate had a negative return on equity of 7.77% and a negative net margin of 4.33%. The firm had revenue of $13.79 billion during the quarter, compared to analyst estimates of $13.68 billion. During the same period in the previous year, the company earned $2.58 earnings per share. Allstate's quarterly revenue was up 11.8% on a year-over-year basis. Research analysts predict that Allstate will post 4.01 EPS for the current year.

Insider Buying and Selling at Allstate

In other Allstate news, CFO Jesse E. Merten sold 29,451 shares of the company's stock in a transaction dated Wednesday, February 22nd. The shares were sold at an average price of $134.18, for a total transaction of $3,951,735.18. Following the completion of the sale, the chief financial officer now directly owns 16,668 shares in the company, valued at $2,236,512.24. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 1.70% of the company's stock.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. Accurate Wealth Management LLC acquired a new position in Allstate in the fourth quarter worth about $27,000. CVA Family Office LLC raised its position in Allstate by 48.4% in the first quarter. CVA Family Office LLC now owns 282 shares of the insurance provider's stock worth $31,000 after purchasing an additional 92 shares in the last quarter. Standard Family Office LLC acquired a new position in Allstate in the third quarter worth about $37,000. Chilton Capital Management LLC acquired a new position in Allstate in the first quarter worth about $33,000. Finally, OLD Mission Capital LLC bought a new stake in Allstate during the fourth quarter worth about $41,000. Institutional investors and hedge funds own 77.48% of the company's stock.

Allstate Company Profile

(Get Rating)

The Allstate Corp. engages in the property and casualty insurance business and the provision of protection solutions. It operates through following business segments: Allstate Protection, Protection Services, Allstate Health and Benefits, Run-off Property-Liability, and Corporate and Other. The Allstate Protection segment offers private passenger auto, homeowners, other personal lines, and commercial insurance marketed under the Allstate, National General, and Answer Financial brand names.

Recommended Stories

The Fly logo

Analyst Recommendations for Allstate (NYSE:ALL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in Allstate right now?

Before you consider Allstate, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.

While Allstate currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here


Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report
Elon Musk's Next Move Cover

Featured Articles and Offers

Search Headlines:

My Account -